Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Jean-Philippe Galons
Associate, Center for Toxicology | Associate Research Professor
Medical Imaging
Overview
Research
More
Collaboration
(74)
Arthur Gmitro
Mutual work: 2 Grants﹒1 Publication﹒8 Proposals
Collaboration Details
Denise Roe
Mutual work: 15 Proposals﹒6 Publications﹒4 Grants
Collaboration Details
Theodore Trouard
Mutual work: 3 Proposals﹒2 Techs﹒17 Publications﹒1 Grant
Collaboration Details
Edward Bedrick
Mutual work: 1 Grant﹒6 Proposals
Collaboration Details
Cynthia Thomson
Mutual work: 3 Grants﹒7 Proposals﹒8 Publications
Collaboration Details
Page 1 of 15
Previous page
Next page
Grants
(9)
Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators
Active
·
2023
·
$0 / $600.2K
·
External
undefined (CD)
renal denervation,
polycystic kidney disease,
mechanisms,
mediators,
treatment
Joint Estimation Diffusion Imaging (JEDI) for Improved Tissue Characterization and Neural Connectivity in Aging and Alzheimer's Disease
Active
·
2023
·
$89.9K / $374.7K
·
External
Co-Investigator (COI)
diffusion imaging,
aging,
alzheimer's disease,
tissue characterization,
neural connectivity
Development of MRI Biomarkers for Improved Risk Stratification of Patients with Carotid Atherosclerosis to Prevent Stroke
Active
·
2021
·
$60K / $749.9K
·
External
Co-Investigator (COI)
mri biomarkers,
risk stratification,
carotid atherosclerosis,
stroke prevention,
medical imaging
Molecular Regulation of Muscle Glucose Metabolism in Man
Active
·
2018
·
$171.6K / $3.4M
·
External
Co-Investigator (COI)
molecular biology,
glucose metabolism,
muscle physiology,
human physiology,
metabolic regulation
MRI of Non-Alcoholic Steatohepatitis (NASH) Biomarkers
2014
·
$74.9K / $749.1K
·
External
Co-Investigator (COI)
mri,
nonalcoholic steatohepatitis,
biomarkers,
liver disease,
medical imaging
Page 1 of 2
Previous page
Next page
Publications
(64)
Recent
Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide D sub 2 sub O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma
2023
cancer,
deuteration,
mice,
tumor growth,
pancreatic cancer
Nonequilibrium thermodynamics and mitochondrial protein content predict insulin sensitivity and fuel selection during exercise in human skeletal muscle
2023
thermodynamics,
insulin sensitivity,
mitochondrial proteins,
exercise,
skeletal muscle
Double pulsed field gradient diffusion MRI to assess skeletal muscle microstructure
2023
mri,
muscle microstructure,
diffusion,
skeletal muscle,
pulsed field gradient
Abdominal T2‐Weighted Imaging and T2 Mapping Using a Variable FliAngle Radial Turbo Spin‐Echo Technique
2022
abdominal imaging,
t2 mapping,
radial imaging,
turbo spin-echo,
variable flip angle
Abdominal T2-weighted Imaging and T2 Mapping using a Variable FliAngle Radial Turbo Spin Echo Technique
2021
abdominal imaging,
t2-weighted imaging,
t2 mapping,
radial imaging,
spin echo technique
Efficient T2 mapping of the Abdomen with low SAR Variable FliAngle Radial Turbo Spin Echo
2021
mri imaging,
abdominal imaging,
radiology,
medical imaging,
mri techniques
Rapid high-resolution volumetric T1 mapping using a highly accelerated Inversion-Recovery Radial FLASH technique
2021
mri imaging,
medical imaging,
volumetric imaging,
accelerated imaging,
t1 mapping
Multi-component T2 Modeling for Improved Characterization of Abdominal Neoplasms
2021
t2 modeling,
abdominal neoplasms,
characterization,
multicomponent,
improved
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density
2021
metformin,
metabolic syndrome,
adiposity,
breast density,
randomized controlled trial
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin
2020
cancer treatment,
mri imaging,
vascular disrupting agents,
dose-response assessment